Autor: |
He, Yeteng, Majid, Khadija, Maqbool, Maimoona, Hussain, Talib, Yousaf, Abid Mehmood, Khan, Ikram Ullah, Mehmood, Yasir, Aleem, Ambreen, Arshad, Muhammad Sohail, Younus, Adnan, Nirwan, Jorabar Singh, Ghori, Muhammad Usman, Rizvi, Syed A.A., Shahzad, Yasser |
Zdroj: |
Saudi Pharmaceutical Journal; Aug2020, Vol. 28 Issue 8, p994-1003, 10p |
Abstrakt: |
Rheumatoid arthritis (RA) is an autoimmune disease associated with severe joint pain. Herein, we report lornoxicam loaded cellulosic microsponge gel formulation with sustained anti-inflammatory effects that are required to manage arthritic pain. The microsponges were formulated using quasi emulsion-solvent diffusion method employing four different surfactant systems, namely polyvinyl alcohol (PVA), Tween80, Gelucire 48/16 and Gelucire 50/13. All the lornoxicam loaded microsponge formulations were extensively characterized with a variety of analytical tools. The optimized microsponge formulation was then converted into gel formulation. The lornoxicam loaded microsponge gel formulation had adequate viscosity and sufficient pharmaceutical properties as confirmed by the texture analysis and the drug release followed Super case II transport. It is noteworthy that we described the preparation of a new cellulosic polymers based microsponge system for delivery of lornoxicam to provide quick as well as lasting (sustained) anti-inflammatory effects in rats using carrageenan induced rat paw edema model. We were able to demonstrate a 72% reduction in inflammation within 4 h using the optimize transdermal gel formulation utilizing Transcutol P as permeation enhancer and with the aid of skin micro-piercing by microneedles, hence, demonstrating the potential of this microsponge gel formulation in arthritis management. [ABSTRACT FROM AUTHOR] |
Databáze: |
Supplemental Index |
Externí odkaz: |
|